Wealth Growth Daily

Health

Sanofi expects Q4 earnings boost from foreign exchange, flu vaccine sales

BY Reuters  • January 4, 2023January 4, 2023
PARIS (Reuters) – French healthcare company Sanofi said on Wednesday that it expected its fourth quarter results, which will be published early next month, to reflect a boost from foreign exchan[...]
Read more
Business Economy Europe Health

Exclusive-Drugmakers to raise prices on at least 350 drugs in U.S. in January

BY Reuters  • December 30, 2022December 31, 2022
By Michael Erman and Julie Steenhuysen NEW YORK (Reuters) – Drugmakers including Pfizer Inc, GlaxoSmithKline PLC, Bristol Myers Squibb, AstraZeneca PLC and Sanofi SA plan to raise prices in the[...]
Read more
Business Economy Europe Health Top News Updated US

Analysis-Chinese airlines primed to take advantage of border opening

BY Reuters  • December 30, 2022December 30, 2022
By Jamie Freed and Sophie Yu SYDNEY/BEIJING (Reuters) – Chinese airlines will be the early winners of the country’s international reopening, analysts say, having kept most widebody planes[...]
Read more
Asia Business Entertainment and Lifestyle Health Updated

Congressional report: U.S. FDA broke own protocols in approving Biogen Alzheimer’s drug

BY Reuters  • December 30, 2022December 30, 2022
By Ahmed Aboulenein WASHINGTON (Reuters) – The U.S. Food and Drug Administration failed to adhere to its own guidance and internal practices during the approval process for Biogen’s Alzhei[...]
Read more
Business Health Top News US

Novartis to pay $245 million to end antitrust cases over Exforge drug generics

BY Reuters  • December 29, 2022December 29, 2022
By Jonathan Stempel NEW YORK (Reuters) -Novartis AG said on Wednesday it will pay $245 million to end antitrust litigation accusing the Swiss drugmaker of trying to delay the launch in the United Stat[...]
Read more
Business Health Updated

Hershey sued over chocolate containing heavy metals

BY Reuters  • December 29, 2022December 29, 2022
By Jonathan Stempel NEW YORK (Reuters) – Hershey Co has been sued by a consumer who accused the company of selling dark chocolate that contains harmful levels of lead and cadmium. In a proposed[...]
Read more
Business Health US

Gilead buys out rights to cancer therapy from Jounce for $67 million

BY Reuters  • December 29, 2022December 29, 2022
(Reuters) – Gilead Sciences will buy all the remaining rights for an experimental cancer therapy, GS-1811, from Jounce Therapeutics for $67 million, the drugmaker said on Tuesday. The amended li[...]
Read more
Business Health Updated US

Analysis-China’s services sector eyes recovery after reopening, but challenges loom

BY Reuters  • December 29, 2022December 29, 2022
By Joe Cash and Engen Tham BEIJING/SHANGHAI (Reuters) – Jordan Li, a restaurant owner in the southwestern Chinese city of Chengdu, hopes desperately that next month’s Lunar New Year holida[...]
Read more
Asia Business Economy Entertainment and Lifestyle Health Top News

Twitter restores suicide prevention feature after Reuters report

BY Reuters  • December 27, 2022December 27, 2022
By Kenneth Li, Paresh Dave and Sheila Dang NEW YORK (Reuters) -Twitter Inc has restored a feature that promotes suicide prevention hotlines and other safety resources to users looking up certain conte[...]
Read more
Business Entertainment and Lifestyle Health Technology Top News Updated
« Previous 1 … 43 44 45 46 47 … 52 Next »
Wealth Growth Daily
PRIVACY POLICY

Copyright © 2026 Wealth Growth Daily. All Rights Reserved.

HIGH RISK WARNING

Trading foreign exchange, stocks, options, or futures on margin carries a high level of risk, and may not be suitable for all investors. Before deciding to trade, you should carefully consider your objectives, financial situation, needs and level of experience. Wealth Growth Daily provides general advice that does not take into account your objectives, financial situation or needs. The content of this website must not be construed as personal advice. The possibility exists that you could sustain a loss in excess of your deposited funds and therefore, you should not speculate with capital that you cannot afford to lose. You should be aware of all the risks associated with trading on margin. You should seek advice from an independent financial advisor. Past performance is not necessarily indicative of future success.

101 Marketside Ave. Suite 404 PMB 318 Ponte Vedra, FL 32081 | (321) 325-1551